Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 1:07:15 DPT Meeting: Panel 2 – Endpoints & Schedule of Events 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 44:50 DPT Meeting: Panel 3 – Operations & Governance 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:02:36 DPT Meeting: Parent Commentary & Advocacy Perspective 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 18:59 DPT Meeting: Key Takeaways & Next Steps 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:22:00 Understanding Duchenne From The Start 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:09:37 Understanding Duchenne Behavioral Challenges (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 19:21 Where Have We Come From & Where are We Going? (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:31:49 The Complexities of Duchenne (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings «1…2122232425»Page 23 of 25
by: Parent Project Muscular Dystrophy
